Hypothalamic Hamartoma Center
2nd International Symposium on Hypothalamic Hamartomas
Despite the rarity of this condition, much emphasis has recently been placed by medical institutions and research faculties around the world upon its treatment and cure, perhaps because it both serves as a model of lesion-based epilepsy, and provides a particular challenge to neurosurgeons.
Significant advances in research and surgical treatment have been made since the Ist International Symposium more than ten years ago, and this 2nd International Symposium will provide a platform for collaboration and education and offer an opportunity to set a road-map for the next ten years of treatment and research.
This Symposium devoted to the treatment of hypothalamic hamartomas is a further expression of the hope that the neurological and neurosurgical communities are giving to patients and families through the continuing development of treatments that will improve their quality of life.Despite the rarity of this condition, much emphasis has recently been placed by medical institutions and research faculties around the world upon its treatment and cure, perhaps because it both serves as a model of lesion-based epilepsy, and provides a particular challenge to neurosurgeons.
Recently developed surgical techniques to remove hypothalamic hamartomas offer new hope for families with children who suffer from these tumors. Barrow Neurological Institute provides comprehensive evaluation, diagnostic testing, and treatment for patients with hypothalamic hamartoma tumors.
Hypothalamic hamartomas (HH) are rare, benign tumors of the hypothalamus, a region of the brain that regulates many critical functions. Hypothalamic hamartomas affect children from infancy onward and commonly cause seizures, precocious puberty, abnormalities in endocrine function and cognitive and behavioral problems. These tumors are most often found during the diagnostic evaluation of patients for epilepsy (particularly gelastic seizures) or precocious puberty.
Hypothalamic Hamartoma Treatment
The Hypothalamic Hamartoma Program treats patients whose treatment by medication is failing. We offer surgical treatment to eradicate the hypothalamic hamartoma lesion.
The specific treatment approach is based upon the individual anatomy of the hypothalamic hamartoma lesion (which varies tremendously from patient to patient) and the patient's unique clinical circumstances. Options include surgical resection by one of four different approaches, and Gamma Knife radiosurgery.
Multidisciplinary team provides treatment for hypothalamic hamartoma
The Hypothalamic Hamartoma Program is made up of a multidisciplinary team designed to provide comprehensive evaluation, diagnostic testing and definitive treatment for patients with hypothalamic hamartoma tumors. Through a team review of medical records, radiographic tests and other diagnostic tests, a treatment plan is created to meet the needs of each patient.
The Hypothalamic Hamartoma team is dedicated to the continuity of care for each patient, including diagnosis, treatment planning, discharge planning and correspondence with other physicians involved in the patient's care. The team also conducts patient care conferences, supports collaboration between clinical and research specialists and facilitates educational programs to advance the diagnosis and treatment of this disease.
Our commitment to the best care
Hypothalamic hamartoma patients experience unusual seizures. It is common for the diagnosis to be missed, and effective treatment to be delayed. As a result, the disease may progress, resulting in worsening seizures, developmental delays, emotional deterioration, and endocrine (hormonal) disturbances. Consequently, we feel it is our obligation to educate the community, including healthcare professionals, locally and worldwide, so that they will be able to properly diagnose patients with hypothalamic hamartoma.
As a rare and challenging disease, we believe that hypothalamic hamartoma patients are best evaluated and treated in centers that specialize in this condition. Our mission is to serve as a resource to the hypothalamic hamartoma community of patients and families throughout the world. We accomplish this goal by offering definitive treatment and education, and conducting research to benefit the hypothalamic hamartoma patients of the future.
For more information, please contact Maggie Bobrowitz, RN at (602) 933-0686 or email@example.com.